Sunday, September 8, 2024

Proximal Disc Hemorrhages Signal Glaucoma Risk

Cup-type hemorrhages linked to faster disease progression.

Sunday, September 8, 2024

Glaucoma in Myopic Eyes Studied

A long-term study supports the impact of IOP reduction on the progression of glaucoma in highly myopic patients.

Sunday, September 8, 2024

CMS Seeks Feedback on Medicare Contractor Consolidation

Agency considers merging jurisdictions and extending contracts to improve efficiency.

Sunday, September 8, 2024

Ciliatech Presents 3-Year Data on Novel Device

New study shows sustained IOP reduction and decreased medication dependence in patients implanted with a cilioscleral interpositioning device.

Thursday, August 29, 2024

First IOP Sensor Implanted in Eye

The IOP-Connect device, currently under development, will provide real-time IOP monitoring from inside the eye.

Tuesday, August 20, 2024

Early Outcomes Show Promise for Inferotemporal Stent Implantation

Novel surgical approach demonstrates significant IOP and medication reductions.

Tuesday, August 20, 2024

Visiox Pharmaceuticals, Ocuvex Therapeutics to Merge

Company officials say the merger will strengthens their ophthalmic portfolio and accelerate  commercialization of products.

Tuesday, August 20, 2024

Study Compares Microshunt to Trabeculectomy

Preserflo device shows efficacy and safety comparable to traditional filtering surgery in a 2-year study.

Tuesday, August 20, 2024

Long-term Study Shows GDD Success

Ahmed ClearPath glaucoma drainage device demonstrates safety and effectiveness over 3 years.

Tuesday, August 20, 2024

Novel Microstent Shows Promise

A study using rabbit models finds the Wistend microstent safe and effective in reducing IOP.

Monday, August 12, 2024

New Visual Field Test Shows Promise

Online circular contrast perimetry demonstrates good repeatability and reliability in glaucoma screening and monitoring, study finds.

Tuesday, August 6, 2024

FDA Adverse Event Database Reveals Lesser-known Drugs Linked to Glaucoma

A Rutgers study analyzes 20 years of FDA records, finding some lesser-known drugs linked to reports of POAG.